1
|
Sang DM, Na IH, Anh DT, Dung DTM, Hang NTT, Phuong-Anh NT, Hai PT, Oanh DTK, Tung TT, Lee SJ, Kwon JH, Kang JS, Han SB, Hai DTT, Nam NH. Novel (E)-3-(3-oxo-4-substituted-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-N-hydroxypropenamides as Histone Deacetylase Inhibitors: Design, Synthesis and Bioevaluation. Chem Biodivers 2023; 20:e202201030. [PMID: 37017259 DOI: 10.1002/cbdv.202201030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Revised: 03/29/2023] [Accepted: 04/05/2023] [Indexed: 04/06/2023]
Abstract
Herein, we report the design, synthesis and evaluation of novel (E)-3-(3-oxo-4-substituted-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-N-hydroxypropenamides (4a-i, 7a-g) targeting histone deacetylases. Three human cancer cell lines were used to test the cytotoxicity of the synthesized compounds (SW620, colon; PC-3, prostate; NCI-H23, lung cancer); inhibitory activity towards HDAC; anticancer activity; as well as their impact on the cell cycle and apoptosis. As a result, compounds 4a-i bearing the alkyl substituents seemed to be less potent than the benzyl-containing compounds 7a-g in all biological assays. Compounds 7e-fwere found to be the most active HDAC inhibitors with IC50 of 1.498 ± 0.020 μM and 1.794 ± 0.159 μM, respectively. In terms of cytotoxicity and anticancer assay, 7e and 7f also showed good activity with IC50 values in the micromolar range. In addition, the cell cycle and apoptosis of SW620 were affected by compound 7f in almost a similar manner to that of reference compound SAHA. Docking assays were carried out for analysis the binding mode and selectivity of this compound toward 8 HDAC isoforms. Overall, our data confirmed that the inhibition of HDAC plays a pivotal role in their anticancer activity.
Collapse
Affiliation(s)
- Doan Minh Sang
- Hanoi University of Pharmacy, Pharmaceutical chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | - Ik Ho Na
- Chungbuk National University, Pharmacy, Osongsaengmyung-1, Heungdeok, Cheongju, Cheongju, KOREA, REPUBLIC OF
| | - Duong Tien Anh
- Hanoi University of Pharmacy, Pharmaceutical chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | - Do Thi Mai Dung
- Hanoi University of Pharmacy, Pharmaceutical chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | - Nguyen Thi Thu Hang
- Hanoi University of Pharmacy, Pharmaceutical Chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | - Nguyen T Phuong-Anh
- Hanoi University of Pharmacy, Pharmaceutical chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | - Pham-The Hai
- Hanoi University of Pharmacy, Pharmaceutical Chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | - Dao Thi Kim Oanh
- Hanoi University of Pharmacy, Pharmaceutical Chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | | | - Soo Jung Lee
- Korea Research Institute of Bioscience and Biotechnology, Biology, Cheongju, Cheongju, KOREA, REPUBLIC OF
| | - Joo Hee Kwon
- Korea Research Institute of Bioscience and Biotechnology, Biology, Cheongju, Cheongju, KOREA, REPUBLIC OF
| | - Jong Soon Kang
- Korea Research Institute of Bioscience and Biotechnology, Biology, Cheongju, Cheongju, KOREA, REPUBLIC OF
| | - Sang-Bae Han
- Chungbuk National University, Pharmacy, Osongsaengmyung-1, Cheongju, KOREA, REPUBLIC OF
| | - Dinh Thi Thanh Hai
- Hanoi University of Pharmacy, Pharmaceutical chemistry, 13-15 Le Thanh Tong, Hanoi, VIET NAM
| | - Nguyen-Hai Nam
- Hanoi University of Pharmacy, Pharmaceutical Chemistry, 13-15 Le Thanh Tong, 0084, Hanoi, VIET NAM
| |
Collapse
|
2
|
Doan SM, Park EJ, Anh DT, Dung DTM, Quang-Bao L, Hai PT, Oanh DTK, Tung TT, Na IH, Kwon JH, Kang JS, Han SB, Hai DTT, Nam NH. Novel (E)-3-(1- substituted-1H-indazol-5-yl)-N-hydroxypropenamides as Histone Deacetylase Inhibitors: Design, Synthesis and Structure-Activity Relationships. NEW J CHEM 2023. [DOI: 10.1039/d2nj04894a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Histone deacetylases are one of the most interesting targets for anticancer drug discovery and developments. Herein, we report the design, synthesis and evaluation of novel N- hydroxypropenamides bearing indazole moiety...
Collapse
|
3
|
Won Jun H, Kyung Lee H, Ho Na I, Jeong Lee S, Kim K, Park G, Sook Kim H, Ju Son D, Kim Y, Tae Hong J, Han SB. The role of CCL2, CCL7, ICAM-1, and VCAM-1 in interaction of endothelial cells and natural killer cells. Int Immunopharmacol 2022; 113:109332. [DOI: 10.1016/j.intimp.2022.109332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Revised: 09/20/2022] [Accepted: 10/07/2022] [Indexed: 11/05/2022]
|